Skip to content
Open·Synced from source June 27, 2026

NOI - Oxford Nanopore Tech. - PromethION 2 Integrated Instrument

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Who can apply

No Set aside used. NONE

About this opportunity

This is a Notice of Intent, not a request for quotation (RFQ). A solicitation document will not be issued, and quotations will not be requested. The National Institutes of Health (NIH), Clinical Center, Department of Laboratory Medicine (DLM) intends to award a sole source firm-fixed-price contract to Oxford Nanopore Technologies Inc. for the procurement of PromethION 2 Integrated Instrument. The purpose of this procurement is to secure Oxford Nanopore PromethION 2 Integrated instrument to be used to perform long read genomic DNA sequencing of patient samples to detect DNA mutations, DNA structural abnormalities (e.g., deletions, insertions, and inversions, etc.), and DNA methylation that are often undetected by commonly used DNA sequencing techniques in the hematology clinical research la...

Finding similar opportunities...